• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cadre Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    10/8/25 8:30:49 AM ET
    $CDRE
    Industrial Specialties
    Health Care
    Get the next $CDRE alert in real time by email
    false 0001860543 0001860543 2025-10-08 2025-10-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    United States

    Securities and Exchange Commission

    Washington, D.C. 20549

     

    Form 8-K

    Current Report 

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): October 8, 2025

     

    CADRE HOLDINGS, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware 001-40698 38-3873146
    (State or other jurisdiction (Commission File Number) (IRS Employer
    of incorporation)   Identification Number)

     

    13386 International Pkwy 32218
    Jacksonville, Florida (Zip Code)
    (Address of principal executive offices)

     

    Registrant’s telephone number, including area code: (904) 741-5400

     

    N/A

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

      x Emerging growth company

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading Symbol Name of each exchange on which
    registered
    Common Stock, par value $.0001 per share CDRE New York Stock Exchange

     

     

     

     

    Item 7.01 Regulation FD Disclosure.

     

    On October 8, 2025, beginning at 10:00 a.m. Eastern Time, representatives of Cadre Holdings, Inc. (the “Company”) will host, as previously announced, an investor day event at the New York Stock Exchange in New York City. The event will feature a slide presentation by the Company’s management, followed by a Q&A session. The investor day will be broadcast live and available for replay on the Company’s website at www.cadre-holdings.com. A copy of the slide presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

     

    The information contained in Exhibit 99.1 attached hereto is being “furnished” pursuant to Item 7.01 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed otherwise subject to the liabilities of that Section. Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly stated by the Company. The Company undertakes no obligation to publicly update or revise the information contained in this Item 7.01 or in Exhibit 99.1.

     

    Item 9.01 Financial Statements and Exhibits

     

    (d) Exhibits.

     

    Exhibit Description  
       
    99.1 Slide Presentation dated October 8, 2025 (furnished only)
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: October 8, 2025

     

      CADRE HOLDINGS, INC.
         
      By: /s/ Blaine Browers
      Name: Blaine Browers
      Title: Chief Financial Officer

      

     

     

    Get the next $CDRE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CDRE

    DatePrice TargetRatingAnalyst
    8/13/2025$26.00Neutral → Underperform
    BofA Securities
    6/13/2025$38.00Buy → Neutral
    BofA Securities
    2/21/2024$32.00 → $38.00Buy
    ROTH MKM
    1/22/2024Outperform → Mkt Perform
    Raymond James
    9/6/2022$30.00Buy
    BofA Securities
    8/31/2022$32.00Buy
    Jefferies
    3/11/2022$25.00 → $27.00Outperform
    Raymond James
    11/29/2021$24.00Buy
    Lake Street
    More analyst ratings

    $CDRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Neutral to Underperform and set a new price target of $26.00

    8/13/25 8:01:40 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings downgraded by BofA Securities with a new price target

    BofA Securities downgraded Cadre Holdings from Buy to Neutral and set a new price target of $38.00

    6/13/25 7:45:51 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ROTH MKM reiterated coverage on Cadre Holdings with a new price target

    ROTH MKM reiterated coverage of Cadre Holdings with a rating of Buy and set a new price target of $38.00 from $32.00 previously

    2/21/24 9:51:23 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cadre Holdings to Host Investor Day on October 8, 2025 in New York City

    Company to Detail Nuclear Momentum and Continued Strong Demand Trends for Mission Critical Safety Equipment Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it will host an Investor Day on Wednesday, October 8, 2025 at the New York Stock Exchange in New York City. The event is scheduled to begin at 10:00 am ET and will feature remarks from Cadre's management team, who will outline the Company's track record of value creation, strategic execution, operating model, future growth opportu

    9/22/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Announces Participation at Upcoming Investor Conferences

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that Brad Williams, President, and Blaine Browers, Chief Financial Officer, are scheduled to participate in the following investor conferences in New York, NY: Jefferies Industrials Conference Date: Thursday, September 4, 2025 Presentation Time: 11:30 a.m. ET Webcast link 8th Annual B Riley Consumer & TMT Conference Date: Wednesday, September 10, 2025 Lake Street Capital Markets Best Ideas Growth Conference Date: Thursday, September 1

    8/21/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Reports Second Quarter 2025 Financial Results

    Increased Quarterly Net Sales 9% and Gross Profit 10% Year-Over-Year Continued Strong Demand Trends for Mission Critical Safety Equipment Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three and six months ended June 30, 2025. Net sales of $157.1 million for the second quarter; net sales of $287.2 million for the six months ended June 30, 2025. Gross profit margin of 40.9% for the second quarter; gross profit margin of 41.9% for the six months

    8/5/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    SEC Filings

    View All

    Cadre Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Cadre Holdings, Inc. (0001860543) (Filer)

    10/8/25 8:30:49 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

    SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    8/12/25 4:16:56 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Cadre Holdings Inc.

    SCHEDULE 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    8/6/25 11:56:23 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT Williams Brad sold $152,884 worth of shares (4,132 units at $37.00), decreasing direct ownership by 3% to 114,353 units (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    9/25/25 4:15:12 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    CEO AND CHAIRMAN Kanders Warren B sold $819,500 worth of shares (25,000 units at $32.78) (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    6/24/25 4:35:50 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    CEO AND CHAIRMAN Kanders Warren B sold $3,348,000 worth of shares (100,000 units at $33.48) (SEC Form 4)

    4 - Cadre Holdings, Inc. (0001860543) (Issuer)

    6/23/25 4:15:18 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Financials

    Live finance-specific insights

    View All

    Cadre Holdings Reports Second Quarter 2025 Financial Results

    Increased Quarterly Net Sales 9% and Gross Profit 10% Year-Over-Year Continued Strong Demand Trends for Mission Critical Safety Equipment Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today its consolidated operating results for the three and six months ended June 30, 2025. Net sales of $157.1 million for the second quarter; net sales of $287.2 million for the six months ended June 30, 2025. Gross profit margin of 40.9% for the second quarter; gross profit margin of 41.9% for the six months

    8/5/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Announces Second Quarter 2025 Earnings and Conference Call Information

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced today that it plans to release financial results for the second quarter that ended on June 30, 2025, on Tuesday, August 5, 2025, after the close of market trading. The company has scheduled a conference call to discuss these results on Wednesday, August 6, 2025, at 10:00 a.m. ET. The conference call will feature remarks by Warren Kanders, CEO and Chairman of the Board; Brad Williams, President; and Blaine Browers, Chief Financial Officer. To partici

    7/23/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Declares Quarterly Dividend of $0.095 Per Share

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, today announced that its Board of Directors has declared a quarterly cash dividend of $0.095 per share, or $0.38 per share on an annualized basis. Cadre's dividend payment will be made on August 15, 2025 to shareholders of record as of the close of business on the record date of August 1, 2025. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors. About Cadre Headquartered in Jacksonville, Florida, Cadre is

    7/22/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    $CDRE
    Leadership Updates

    Live Leadership Updates

    View All

    Cadre Holdings Appoints Gianmaria Delzanno to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety equipment and other related products for the law enforcement, first responder, military and nuclear markets, announced the appointment of Gianmaria Delzanno to its board of directors, effective as of January 13, 2025. Current Director Nicholas Sokolow, who joined the board of Cadre's predecessor in July of 2012, will retire from the Company's board, effective as of January 31, 2025. Upon Mr. Sokolow's departure, Mr. Delzanno will replace Mr. Sokolow as the lead independent director and will also serve as Chairman of the Nominating and Corporate Governance Committee as

    1/13/25 4:15:00 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    Cadre Holdings Appoints Deborah DeCotis to its Board of Directors

    Cadre Holdings, Inc. (NYSE:CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced the appointment of Deborah DeCotis to its board of directors, effective immediately. With Ms. DeCotis' appointment, the Board will expand to five directors, four of whom are independent. Ms. DeCotis will also serve on the Company's Compensation Committee. Ms. DeCotis has over 45 years of financial, advisory and business operations experience with a successful track record of leadership across multiple global institutions and industries. She currently serves as Advisory Director at Morgan Stanley & Co., Inc.

    4/12/22 8:30:00 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    ElectraMeccanica Appoints Automotive Veteran, William Quigley III, to Board of Directors

    VANCOUVER, British Columbia, April 07, 2022 (GLOBE NEWSWIRE) -- ElectraMeccanica Vehicles Corp. (NASDAQ:SOLO) ("ElectraMeccanica" or the "Company"), a designer and manufacturer of electric vehicles revolutionizing the urban driving experience, today announced the appointment of William (Bill) Quigley III to its Board of Directors. Mr. Quigley is an accomplished leader with a proven track record in large enterprises specific to the automotive industry. With 30 plus years in the industry, Bill's career has included the following key roles: Executive Vice President and Chief Financial Officer at Dana Holding Corporation, an automotive, commercial vehicle and off-highway driveline, sealing an

    4/7/22 8:05:00 AM ET
    $CDRE
    $SOLO
    Industrial Specialties
    Health Care
    Auto Manufacturing
    Consumer Discretionary

    $CDRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cadre Holdings Inc.

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    11/12/24 9:50:14 AM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G filed by Cadre Holdings Inc.

    SC 13G - Cadre Holdings, Inc. (0001860543) (Subject)

    2/14/24 7:58:49 PM ET
    $CDRE
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Cadre Holdings Inc. (Amendment)

    SC 13G/A - Cadre Holdings, Inc. (0001860543) (Subject)

    2/12/24 4:15:31 PM ET
    $CDRE
    Industrial Specialties
    Health Care